Feasibility of therapeutic drug monitoring of sorafenib in patients with liver or thyroid cancer

Keyphrases

• Therapeutic Drug Monitoring 100%
• Liver Cancer 100%
• Thyroid Cancer 100%
• Sorafenib 100%
• Ctrough 100%
• Renal Cell Carcinoma 12%
• Patient Dose 12%
• Inter-individual Variability 12%
• Tyrosine Kinase Inhibitor 12%
• Dose Escalation 12%
• Target Concentration 12%
• Hepatocellular Carcinoma 12%
• Recommended Dose 12%
• Dose Adjustment 12%
• Trough Level 12%
• Desmoid-type Fibromatosis 12%
• Dosing Schedule 12%
• Daily Clinical Practice 12%
• Thyroid Carcinoma 12%
• Dose Increase 12%
• Specified Time 12%
• Scientific Rationale 12%
• Carcinoma Thyroid 12%
• Carcinoma Hepatocellular 12%
• During Treatment 12%

Pharmacology, Toxicology and Pharmaceutical Science

• Therapeutic Drug Monitoring 100%
• Thyroid Cancer 100%
• Sorafenib 100%
• Liver Cancer 100%
• Protein Tyrosine Kinase Inhibitor 16%
• Liver Cell Carcinoma 16%
• Trough Level 16%
• Thyroid Carcinoma 16%
• Renal Cell Carcinoma 16%
• Fibromatosis 16%